Kidney and urologic disease status update: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 520: Line 520:
| style="padding: 5px 5px; background: #F5F5F5;" |Electrolyte imbalance (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |Electrolyte imbalance (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehdi
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hyponatremia
| style="padding: 5px 5px; background: #F5F5F5;" |Hyponatremia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mahshid
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypernatremia
| style="padding: 5px 5px; background: #F5F5F5;" |Hypernatremia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Feham
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypokalemia
| style="padding: 5px 5px; background: #F5F5F5;" |Hypokalemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Rc-Aida
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mahshid
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperkalemia
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperkalemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Jogeet
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypocalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |Hypocalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypercalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |Hypercalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sudarshana Datta
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-

Revision as of 00:51, 8 July 2020

System leader: Maneesha Nandimandalam, MD

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases
  • Abderhalden-Kaufmann-Lignac syndrome
  • Analgesic nephropathy
 Assigned Shakiba Elsaiey, Ahmed
  • Balkan nephropathy
  • Continuous veno-venous hemofiltration
  • Contrast-induced acute kidney injury
  • Dent's disease
  • Dialysis (LP)
  • Diuresis
  • Fibrillary immunotactoid glomerulopathy
  • Glomerulosclerosis
  • Hypophosphatemia
  • Haff disease
  • Hemodialysis (SP)
  • HIV associated nephropathy
 Assigned Shakiba Elsaiey,Ahmed Completed
  • Hypertensive nephropathy
 Assigned Nasrin Elsaiey,Ahmed
  • Kidney transplantation
  • Milk-alkali syndrome
  • Multicystic dysplastic kidney
  • Nephroptosis
  • Nutcracker syndrome
  • Papillorenal syndrome
  • Peritoneal dialysis (SP)
  • Phosphate nephropathy
 Assingned Ayesha FJ Sogand
  • Pyonephrosis
  • Rhabdomyolysis
 Assingned Ayesha FJ, Sogand
  • Rebound diuresis
  • Renal agenesis
  • Renal artery stenosis
  • Renal papillary necrosis
  • Thin basement membrane disease

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Cardiorenal syndrome Assigned Dina Huda

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Electrolyte imbalance (LP) Mehdi Yes Done Mehrian
Hyponatremia Saeedeh Yes Done Mahshid
Hypernatremia Feham Yes Done Elsaiey
Hypokalemia Rc-Aida Yes Done Mahshid
Hyperkalemia Jogeet Yes Done Amandeep
Hypocalcemia Krishna Yes Done Hasan
Hypercalcemia Anmol Yes Done Sudarshana Datta
Glomerular Disease(LP)
Lupus Nephritis
Rapidly progressive glomerulonephritis
Membranous glomerulonephritis
Membranoproliferative glomerulonephritis
IgA nephropathy
Goodpastures syndrome
Amyloidosis (LP)
Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type(senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
Hydronephrosis
Kidney stone
Polycystic kidney disease
Nephritic syndrome
Nephrotic syndrome
Post-streptococcal glomerulonephritis
Renal cell carcinoma
Renal osteodystrophy
Renal tubular acidosis
Renal vein thrombosis
Wilms' tumor
Retrieved from "https://www.wikidoc.org/index.php?title=Kidney_and_urologic_disease_status_update&oldid=1622482"